SB
GILD icon

Strategic Blueprint’s Gilead Sciences GILD Stock Holding History

Strategic Blueprint’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Buy
2,819
+349
+14% +$46K 0.02% 539
2026
Q1 		$344K Buy
2,470
+276
+13% +$38.6K 0.02% 490
2025
Q4 		$269K Sell
2,194
-857
-28% -$104K 0.02% 548
2025
Q3 		$339K Buy
3,051
+185
+6% +$21K 0.01% 579
2025
Q2 		$318K Sell
2,866
-313
-10% -$33.3K 0.02% 545
2025
Q1 		$356K Buy
3,179
+429
+16% +$44.3K 0.02% 496
2024
Q4 		$254K Buy
2,750
+192
+8% +$17.3K 0.02% 568
2024
Q3 		$214K Sell
2,558
-572
-18% -$43.6K 0.01% 607
2024
Q2 		$215K Sell
3,130
-288
-8% -$19.2K 0.01% 576
2024
Q1 		$250K Sell
3,418
-553
-14% -$42.5K 0.02% 530
2023
Q4 		$322K Sell
3,971
-417
-10% -$32.5K 0.03% 432
2023
Q3 		$329K Buy
4,388
+328
+8% +$25.2K 0.03% 397
2023
Q2 		$313K Buy
4,060
+26
+0.6% +$2.07K 0.03% 412
2023
Q1 		$335K Buy
4,034
+414
+11% +$34.3K 0.03% 378
2022
Q4 		$311K Buy
+3,620
New +$287K 0.04% 387
2022
Q2 		– Sell
-3,555
Closed -$211K – 516
2022
Q1 		$211K Buy
+3,555
New +$227K 0.02% 470
2021
Q3 		– Sell
-334
Closed -$23K – 747
2021
Q2 		$23K Buy
+334
New +$22.3K ﹤0.01% 778
2020
Q2 		– Sell
-3,404
Closed -$254K – 177
2020
Q1 		$254K Buy
+3,404
New +$235K 0.15% 96

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Strategic Blueprint's GILD Position: Q2 2026 in Review

Strategic Blueprint increased its Gilead Sciences (GILD) stake by 14% in Q2 2026, buying an estimated $46K and bringing the position to 2,819 shares worth $356K. The position accounts for 0.02% of the portfolio, ranked #539.

Strategic Blueprint first reported a position in GILD in Q1 2020 and has held it in 18 quarters since. The position peaked at $356K in Q1 2025. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Strategic Blueprint held 2,819 shares of Gilead Sciences worth $356K as of Q2 2026.
  • Strategic Blueprint bought 349 Gilead Sciences shares in Q2 2026, an estimated $46K.
  • Gilead Sciences made up 0.02% of Strategic Blueprint's portfolio in Q2 2026, its #539 holding.
  • Strategic Blueprint first reported a position in Gilead Sciences in Q1 2020 and has held it in 18 quarters since.
  • Strategic Blueprint's Gilead Sciences position peaked at $356K in Q1 2025.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Strategic Blueprint's 13F filing for Q2 2026, filed 23 Jul 2026.